Dimensional Fund Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$383M Buy
6,097,777
+362,547
+6% +$29M 0.08% 246
2025
Q4
$547M Buy
5,735,230
+1,420,907
+33% +$139M 0.11% 128
2025
Q3
$421M Buy
4,314,323
+196,830
+5% +$20.4M 0.09% 187
2025
Q2
$442M Sell
4,117,493
-543,823
-12% -$55M 0.1% 153
2025
Q1
$470M Sell
4,661,316
-253,126
-5% -$25.5M 0.12% 124
2024
Q4
$439M Buy
4,914,442
+22,621
+0.5% +$1.99M 0.11% 140
2024
Q3
$410M Sell
4,891,821
-155,840
-3% -$12.3M 0.1% 164
2024
Q2
$389M Buy
5,047,661
+411,628
+9% +$30.1M 0.1% 152
2024
Q1
$318M Buy
4,636,033
+107,016
+2% +$6.88M 0.09% 206
2023
Q4
$262M Buy
4,529,017
+739,940
+20% +$39.5M 0.08% 264
2023
Q3
$200M Buy
3,789,077
+469,469
+14% +$24.6M 0.07% 327
2023
Q2
$180M Buy
3,319,608
+115,787
+4% +$6.05M 0.06% 392
2023
Q1
$160M Buy
3,203,821
+74,092
+2% +$3.49M 0.05% 444
2022
Q4
$145K Buy
3,129,729
+14,061
+0.5% +$609K 0.04% 509
2022
Q3
$121M Buy
3,115,668
+162,965
+6% +$6.54M 0.05% 559
2022
Q2
$110M Sell
2,952,703
-5,436
-0.2% -$221K 0.04% 649
2022
Q1
$131M Sell
2,958,139
-72,091
-2% -$3.12M 0.04% 632
2021
Q4
$129M Buy
3,030,230
+65,030
+2% +$2.73M 0.04% 672
2021
Q3
$129M Sell
2,965,200
-2,626
-0.1% -$116K 0.04% 624
2021
Q2
$127M Sell
2,967,826
-14,210
-0.5% -$598K 0.04% 642
2021
Q1
$115M Sell
2,982,036
-62,369
-2% -$2.36M 0.04% 705
2020
Q4
$109M Buy
3,044,405
+124,393
+4% +$4.48M 0.04% 665
2020
Q3
$112M Buy
2,920,012
+100,674
+4% +$3.88M 0.05% 500
2020
Q2
$99M Buy
2,819,338
+159,110
+6% +$5.73M 0.04% 567
2020
Q1
$86.8M Buy
2,660,228
+32,651
+1% +$1.28M 0.05% 524
2019
Q4
$119M Sell
2,627,577
-17,091
-0.6% -$715K 0.04% 595
2019
Q3
$108M Sell
2,644,668
-261,173
-9% -$11.1M 0.04% 617
2019
Q2
$125M Sell
2,905,841
-58,411
-2% -$2.25M 0.05% 505
2019
Q1
$114M Sell
2,964,252
-14,193
-0.5% -$542K 0.05% 562
2018
Q4
$105M Buy
2,978,445
+51,606
+2% +$1.87M 0.05% 504
2018
Q3
$113M Buy
2,926,839
+30,832
+1% +$1.08M 0.04% 608
2018
Q2
$94.7M Buy
2,896,007
+151,609
+6% +$4.57M 0.04% 697
2018
Q1
$75M Buy
2,744,398
+133,462
+5% +$3.63M 0.03% 884
2017
Q4
$64.7M Buy
2,610,936
+23,001
+0.9% +$634K 0.03% 1058
2017
Q3
$75.5M Buy
2,587,935
+68
+0% +$1.88K 0.03% 816
2017
Q2
$71.7M Sell
2,587,867
-229,844
-8% -$6.1M 0.03% 817
2017
Q1
$70.1M Sell
2,817,711
-1,832,733
-39% -$44.6M 0.03% 796
2016
Q4
$101M Sell
4,650,444
-1,418,230
-23% -$30.9M 0.05% 501
2016
Q3
$144M Sell
6,068,674
-30,018
-0.5% -$716K 0.08% 255
2016
Q2
$143M Sell
6,098,692
-336,789
-5% -$7.29M 0.08% 232
2016
Q1
$121M Sell
6,435,481
-1,534,830
-19% -$27M 0.07% 280
2015
Q4
$147M Sell
7,970,311
-2,177,853
-21% -$39M 0.09% 195
2015
Q3
$167M Sell
10,148,164
-2,075,982
-17% -$35.5M 0.11% 141
2015
Q2
$216M Sell
12,224,146
-373,656
-3% -$6.68M 0.13% 103
2015
Q1
$224M Sell
12,597,802
-398,367
-3% -$6.3M 0.14% 97
2014
Q4
$172M Buy
12,996,169
+176,402
+1% +$2.26M 0.11% 152
2014
Q3
$151M Sell
12,819,767
-535,865
-4% -$6.75M 0.11% 158
2014
Q2
$171M Sell
13,355,632
-18,827
-0.1% -$245K 0.12% 132
2014
Q1
$181M Sell
13,374,459
-1,116,587
-8% -$14.7M 0.14% 111
2013
Q4
$174M Buy
14,491,046
+21,525
+0.1% +$254K 0.14% 112
2013
Q3
$170M Buy
14,469,521
+131,315
+0.9% +$1.42M 0.15% 103
2013
Q2
$133M Buy
+14,338,206
New +$122M 0.13% 135

Other funds holding BSX

Dimensional Fund Advisors's BSX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Boston Scientific (BSX) stake by 6.3% in Q1 2026, buying an estimated $29M and bringing the position to 6,097,777 shares worth $383M. The position accounts for 0.08% of the portfolio, ranked #246.

Dimensional Fund Advisors first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $547M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Dimensional Fund Advisors held 6,097,777 shares of Boston Scientific worth $383M as of Q1 2026.
  • Dimensional Fund Advisors bought 362,547 Boston Scientific shares in Q1 2026, an estimated $29M.
  • Boston Scientific made up 0.08% of Dimensional Fund Advisors's portfolio in Q1 2026, its #246 holding.
  • Dimensional Fund Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Boston Scientific position peaked at $547M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.